Sophie Van Welden (Ir. Ph.D) was educated as bioengineer and obtained a Ph.D. in medicine and health sciences. Her research focusses on the role of hypoxia-induced signaling in inflammatory bowel diseases (IBD) and colorectal cancer. Since her PhD, she is first author of 3 publications (2 in top 5% ranked journals) and co-authored 5 additional publications in the gastroenterology field. Sophie Van Welden obtained 2 personal postdoctoral mandates from the research foundation of Flanders (FWO) and the current fellowship from Ghent University (BOF). She received several travel grants and the inflammatory Bowel Disease Research and Development research grant in 2020.